Exact Sciences Clarifies Colorectal Cancer Test Status, Touts Tech’s Benefits

Exact Sciences and licensing partner LabCorp are newly committed to improving appreciation for stool-based DNA testing, confident that their PreGen-Plus colorectal cancer screening assay meets FDA criteria as a "homebrew" exempt from agency oversight